IL164530A - Polypeptide fragments of nf-kb inducing kinase (nik), their preparation and pharmaceuticalcompositions comprising them or nik - Google Patents

Polypeptide fragments of nf-kb inducing kinase (nik), their preparation and pharmaceuticalcompositions comprising them or nik

Info

Publication number
IL164530A
IL164530A IL164530A IL16453004A IL164530A IL 164530 A IL164530 A IL 164530A IL 164530 A IL164530 A IL 164530A IL 16453004 A IL16453004 A IL 16453004A IL 164530 A IL164530 A IL 164530A
Authority
IL
Israel
Prior art keywords
nik
pharmaceuticalcompositions
preparation
polypeptide fragments
inducing kinase
Prior art date
Application number
IL164530A
Other languages
Hebrew (he)
Other versions
IL164530A0 (en
Inventor
David Wallach
Parameswaran Ramakrishnan
Taisia Shmushkovich
Original Assignee
Yeda Res & Dev
David Wallach
Parameswaran Ramakrishnan
Taisia Shmushkovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14921702A external-priority patent/IL149217A0/en
Priority claimed from IL15218302A external-priority patent/IL152183A0/en
Priority claimed from PCT/IL2003/000317 external-priority patent/WO2003087380A1/en
Application filed by Yeda Res & Dev, David Wallach, Parameswaran Ramakrishnan, Taisia Shmushkovich filed Critical Yeda Res & Dev
Priority to IL164530A priority Critical patent/IL164530A/en
Publication of IL164530A0 publication Critical patent/IL164530A0/en
Publication of IL164530A publication Critical patent/IL164530A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention relates to the use of NIK (NF-kappaB Inducing Kinase) and related molecules for the modulation of signal activities controlled by cytokines, and some new such molecules.
IL164530A 2002-04-18 2004-10-12 Polypeptide fragments of nf-kb inducing kinase (nik), their preparation and pharmaceuticalcompositions comprising them or nik IL164530A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL164530A IL164530A (en) 2002-04-18 2004-10-12 Polypeptide fragments of nf-kb inducing kinase (nik), their preparation and pharmaceuticalcompositions comprising them or nik

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL14921702A IL149217A0 (en) 2002-04-18 2002-04-18 Derivatives of the il-2 receptor gamma chain, their preparation and use
IL15218302A IL152183A0 (en) 2002-10-08 2002-10-08 Derivatives of the il-2 receptor gamma chain, their preparation and use
PCT/IL2003/000317 WO2003087380A1 (en) 2002-04-18 2003-04-15 Derivatives of the nf-kappab inducing enzyme, their preparation and use
IL164530A IL164530A (en) 2002-04-18 2004-10-12 Polypeptide fragments of nf-kb inducing kinase (nik), their preparation and pharmaceuticalcompositions comprising them or nik

Publications (2)

Publication Number Publication Date
IL164530A0 IL164530A0 (en) 2005-12-18
IL164530A true IL164530A (en) 2013-10-31

Family

ID=36650024

Family Applications (1)

Application Number Title Priority Date Filing Date
IL164530A IL164530A (en) 2002-04-18 2004-10-12 Polypeptide fragments of nf-kb inducing kinase (nik), their preparation and pharmaceuticalcompositions comprising them or nik

Country Status (1)

Country Link
IL (1) IL164530A (en)

Also Published As

Publication number Publication date
IL164530A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
RS20060320A (en) Substituted indazole-o-glucosides
MY142777A (en) Substituted indole-o-glucosides
UA87991C2 (en) Substituted indole-o-glucosides
YU9404A (en) Peptide-based multimeric targeted contrast agents
TNSN06058A1 (en) Thienopyrazoles
WO2003048301A3 (en) Anti-hla-dr antibodies and the methods of using thereof
DE60128701D1 (en) Claudin polypeptide
WO2003103571A3 (en) Flavivirus vaccines
AP2004002995A0 (en) Combination therapy for the treatment of cancer
WO2003104425A3 (en) Novel stable anti-cd22 antibodies
MXPA03010158A (en) Sulfonamides.
EP1978994A4 (en) Bmp-7 variant compositions, methods and uses
BRPI0013875B8 (en) directly pressable raw material for compressed products
WO2002002630A3 (en) Hcn polypeptides and polynucleotides and their use in therapy
AU762955C (en) Methods and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
MXPA03008039A (en) Human serpin polypeptides.
IL164530A (en) Polypeptide fragments of nf-kb inducing kinase (nik), their preparation and pharmaceuticalcompositions comprising them or nik
WO2005115456A3 (en) METHODS OF MODULATING THE REPRODUCTIVE ENDOCRINE SYSTEM BY MODULATION OF TNFαACTIVITY
MXPA04000272A (en) Substituted 4-aminocyclohexanol derivatives.
AU2003211040A8 (en) The eaat2 promoter and uses thereof
WO2002089740A3 (en) Sulfonamides
HK1082510A1 (en) Promoter to il-18bp, its preparation and use
TW200505435A (en) Treatment of ocular disorders
AU2002251873A1 (en) Methods and compositions for modulating gluconeogenesis using pgc-1
WO2004016810A3 (en) Use of an mrp4 binding substances for the diagnosis and treatment of cancer

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees